The study looked back on their health records for up to three years, beginning when they started taking either a GLP-1 receptor agonist most commonly semaglutide, liraglutide or dulaglutide or another type of medication, called an SGLT2 inhibitor, to treat their diabetes
Not yet, and probably not for some time
Recommended dose: 2g daily
Interestingly, while BPC-157 promotes healing-associated angiogenesis, research also demonstrates it can inhibit tumor-promoting effects of VEGF signaling via the MAPK pathway in melanoma cell lines, suggesting context-dependent modulation of vascular growth that may preferentially support physiological tissue repair over pathological neovascularization
If everything checks out, a licensed provider can approve your request, often within a day or two